Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study
To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD).
Autor*in: |
Singh, Dave [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Schlagwörter: |
Long acting anti-muscarinic agent (LAMA) |
---|
Umfang: |
6 |
---|
Übergeordnetes Werk: |
Enthalten in: Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape - Jellinek, Sacha ELSEVIER, 2013, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:37 ; year:2016 ; pages:9-14 ; extent:6 |
Links: |
---|
DOI / URN: |
10.1016/j.pupt.2016.01.003 |
---|
Katalog-ID: |
ELV040181065 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV040181065 | ||
003 | DE-627 | ||
005 | 20230624071355.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.pupt.2016.01.003 |2 doi | |
028 | 5 | 2 | |a GBVA2016019000010.pica |
035 | |a (DE-627)ELV040181065 | ||
035 | |a (ELSEVIER)S1094-5539(16)30003-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 570 |q VZ |
082 | 0 | 4 | |a 540 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 630 |q VZ |
084 | |a 22 |2 ssgn | ||
084 | |a 46.00 |2 bkl | ||
100 | 1 | |a Singh, Dave |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study |
264 | 1 | |c 2016 | |
300 | |a 6 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). | ||
650 | 7 | |a Glycopyrronium bromide |2 Elsevier | |
650 | 7 | |a Long acting anti-muscarinic agent (LAMA) |2 Elsevier | |
650 | 7 | |a Pressurised metered-dose inhaler (pMDI) |2 Elsevier | |
650 | 7 | |a COPD |2 Elsevier | |
700 | 1 | |a Ravi, Arjun |4 oth | |
700 | 1 | |a Reid, Frederick |4 oth | |
700 | 1 | |a Buck, Helen |4 oth | |
700 | 1 | |a O'Connor, Gemma |4 oth | |
700 | 1 | |a Down, Geoff |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Jellinek, Sacha ELSEVIER |t Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape |d 2013 |g Amsterdam [u.a.] |w (DE-627)ELV022192794 |
773 | 1 | 8 | |g volume:37 |g year:2016 |g pages:9-14 |g extent:6 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.pupt.2016.01.003 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 46.00 |j Tiermedizin: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 37 |j 2016 |h 9-14 |g 6 | ||
953 | |2 045F |a 610 |
author_variant |
d s ds |
---|---|
matchkey_str |
singhdaveraviarjunreidfrederickbuckhelen:2016----:rnhdltrfetpamckntcadaeyfs10gaoegyoyrnuboieomltoic |
hierarchy_sort_str |
2016 |
bklnumber |
46.00 |
publishDate |
2016 |
allfields |
10.1016/j.pupt.2016.01.003 doi GBVA2016019000010.pica (DE-627)ELV040181065 (ELSEVIER)S1094-5539(16)30003-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Singh, Dave verfasserin aut Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD Elsevier Ravi, Arjun oth Reid, Frederick oth Buck, Helen oth O'Connor, Gemma oth Down, Geoff oth Enthalten in Elsevier Jellinek, Sacha ELSEVIER Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape 2013 Amsterdam [u.a.] (DE-627)ELV022192794 volume:37 year:2016 pages:9-14 extent:6 https://doi.org/10.1016/j.pupt.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 37 2016 9-14 6 045F 610 |
spelling |
10.1016/j.pupt.2016.01.003 doi GBVA2016019000010.pica (DE-627)ELV040181065 (ELSEVIER)S1094-5539(16)30003-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Singh, Dave verfasserin aut Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD Elsevier Ravi, Arjun oth Reid, Frederick oth Buck, Helen oth O'Connor, Gemma oth Down, Geoff oth Enthalten in Elsevier Jellinek, Sacha ELSEVIER Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape 2013 Amsterdam [u.a.] (DE-627)ELV022192794 volume:37 year:2016 pages:9-14 extent:6 https://doi.org/10.1016/j.pupt.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 37 2016 9-14 6 045F 610 |
allfields_unstemmed |
10.1016/j.pupt.2016.01.003 doi GBVA2016019000010.pica (DE-627)ELV040181065 (ELSEVIER)S1094-5539(16)30003-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Singh, Dave verfasserin aut Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD Elsevier Ravi, Arjun oth Reid, Frederick oth Buck, Helen oth O'Connor, Gemma oth Down, Geoff oth Enthalten in Elsevier Jellinek, Sacha ELSEVIER Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape 2013 Amsterdam [u.a.] (DE-627)ELV022192794 volume:37 year:2016 pages:9-14 extent:6 https://doi.org/10.1016/j.pupt.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 37 2016 9-14 6 045F 610 |
allfieldsGer |
10.1016/j.pupt.2016.01.003 doi GBVA2016019000010.pica (DE-627)ELV040181065 (ELSEVIER)S1094-5539(16)30003-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Singh, Dave verfasserin aut Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD Elsevier Ravi, Arjun oth Reid, Frederick oth Buck, Helen oth O'Connor, Gemma oth Down, Geoff oth Enthalten in Elsevier Jellinek, Sacha ELSEVIER Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape 2013 Amsterdam [u.a.] (DE-627)ELV022192794 volume:37 year:2016 pages:9-14 extent:6 https://doi.org/10.1016/j.pupt.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 37 2016 9-14 6 045F 610 |
allfieldsSound |
10.1016/j.pupt.2016.01.003 doi GBVA2016019000010.pica (DE-627)ELV040181065 (ELSEVIER)S1094-5539(16)30003-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Singh, Dave verfasserin aut Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD Elsevier Ravi, Arjun oth Reid, Frederick oth Buck, Helen oth O'Connor, Gemma oth Down, Geoff oth Enthalten in Elsevier Jellinek, Sacha ELSEVIER Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape 2013 Amsterdam [u.a.] (DE-627)ELV022192794 volume:37 year:2016 pages:9-14 extent:6 https://doi.org/10.1016/j.pupt.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 37 2016 9-14 6 045F 610 |
language |
English |
source |
Enthalten in Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape Amsterdam [u.a.] volume:37 year:2016 pages:9-14 extent:6 |
sourceStr |
Enthalten in Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape Amsterdam [u.a.] volume:37 year:2016 pages:9-14 extent:6 |
format_phy_str_mv |
Article |
bklname |
Tiermedizin: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
Glycopyrronium bromide Long acting anti-muscarinic agent (LAMA) Pressurised metered-dose inhaler (pMDI) COPD |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape |
authorswithroles_txt_mv |
Singh, Dave @@aut@@ Ravi, Arjun @@oth@@ Reid, Frederick @@oth@@ Buck, Helen @@oth@@ O'Connor, Gemma @@oth@@ Down, Geoff @@oth@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
ELV022192794 |
dewey-sort |
3610 |
id |
ELV040181065 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040181065</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624071355.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pupt.2016.01.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016019000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040181065</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1094-5539(16)30003-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">22</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">46.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Singh, Dave</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glycopyrronium bromide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Long acting anti-muscarinic agent (LAMA)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pressurised metered-dose inhaler (pMDI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COPD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ravi, Arjun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reid, Frederick</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buck, Helen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O'Connor, Gemma</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Down, Geoff</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Jellinek, Sacha ELSEVIER</subfield><subfield code="t">Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV022192794</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:9-14</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pupt.2016.01.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">46.00</subfield><subfield code="j">Tiermedizin: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2016</subfield><subfield code="h">9-14</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Singh, Dave |
spellingShingle |
Singh, Dave ddc 610 ddc 570 ddc 540 ddc 630 ssgn 22 bkl 46.00 Elsevier Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study |
authorStr |
Singh, Dave |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV022192794 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences 630 - Agriculture & related technologies |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 570 VZ 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD Elsevier |
topic |
ddc 610 ddc 570 ddc 540 ddc 630 ssgn 22 bkl 46.00 Elsevier Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD |
topic_unstemmed |
ddc 610 ddc 570 ddc 540 ddc 630 ssgn 22 bkl 46.00 Elsevier Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD |
topic_browse |
ddc 610 ddc 570 ddc 540 ddc 630 ssgn 22 bkl 46.00 Elsevier Glycopyrronium bromide Elsevier Long acting anti-muscarinic agent (LAMA) Elsevier Pressurised metered-dose inhaler (pMDI) Elsevier COPD |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
a r ar f r fr h b hb g o go g d gd |
hierarchy_parent_title |
Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape |
hierarchy_parent_id |
ELV022192794 |
dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry 630 - Agriculture |
hierarchy_top_title |
Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV022192794 |
title |
Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study |
ctrlnum |
(DE-627)ELV040181065 (ELSEVIER)S1094-5539(16)30003-7 |
title_full |
Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study |
author_sort |
Singh, Dave |
journal |
Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape |
journalStr |
Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
zzz |
container_start_page |
9 |
author_browse |
Singh, Dave |
container_volume |
37 |
physical |
6 |
class |
610 610 DE-600 570 VZ 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Singh, Dave |
doi_str_mv |
10.1016/j.pupt.2016.01.003 |
dewey-full |
610 570 540 630 |
title_sort |
bronchodilator effects, pharmacokinetics and safety of psx1002-gb, a novel glycopyrronium bromide formulation, in copd patients; a randomised crossover study |
title_auth |
Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study |
abstract |
To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). |
abstractGer |
To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). |
abstract_unstemmed |
To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD). |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
title_short |
Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study |
url |
https://doi.org/10.1016/j.pupt.2016.01.003 |
remote_bool |
true |
author2 |
Ravi, Arjun Reid, Frederick Buck, Helen O'Connor, Gemma Down, Geoff |
author2Str |
Ravi, Arjun Reid, Frederick Buck, Helen O'Connor, Gemma Down, Geoff |
ppnlink |
ELV022192794 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth |
doi_str |
10.1016/j.pupt.2016.01.003 |
up_date |
2024-07-06T16:51:24.429Z |
_version_ |
1803849233264017408 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040181065</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624071355.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pupt.2016.01.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016019000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040181065</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1094-5539(16)30003-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">22</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">46.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Singh, Dave</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glycopyrronium bromide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Long acting anti-muscarinic agent (LAMA)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pressurised metered-dose inhaler (pMDI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COPD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ravi, Arjun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reid, Frederick</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buck, Helen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O'Connor, Gemma</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Down, Geoff</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Jellinek, Sacha ELSEVIER</subfield><subfield code="t">Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV022192794</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:9-14</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pupt.2016.01.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">46.00</subfield><subfield code="j">Tiermedizin: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2016</subfield><subfield code="h">9-14</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.398837 |